157 related articles for article (PubMed ID: 8841317)
1. Factor V Leiden mutation in cerebral venous thrombosis.
Zuber M; Toulon P; Marnet L; Mas JL
Stroke; 1996 Oct; 27(10):1721-3. PubMed ID: 8841317
[TBL] [Abstract][Full Text] [Related]
2. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG
Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318
[TBL] [Abstract][Full Text] [Related]
3. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
[TBL] [Abstract][Full Text] [Related]
4. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
Dindagur N; Kruthika-Vinod TP; Christopher R
Thromb Res; 2007; 119(4):497-500. PubMed ID: 16781765
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients.
Lüdemann P; Nabavi DG; Junker R; Wolff E; Papke K; Buchner H; Assmann G; Ringelstein EB
Stroke; 1998 Dec; 29(12):2507-10. PubMed ID: 9836759
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.
Hallak M; Senderowicz J; Cassel A; Shapira C; Aghai E; Auslender R; Abramovici H
Am J Obstet Gynecol; 1997 Apr; 176(4):889-93. PubMed ID: 9125617
[TBL] [Abstract][Full Text] [Related]
9. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral contraceptives on hemostasis and thrombosis.
Rosing J; Tans G
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group.
de Bruijn SF; Stam J; Koopman MM; Vandenbroucke JP
BMJ; 1998 Feb; 316(7131):589-92. PubMed ID: 9518910
[TBL] [Abstract][Full Text] [Related]
12. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis.
Weih M; Vetter B; Ziemer S; Mehraein S; Valdueza JM; Koscielny J; Kulozik AE; Einhäupl KM
J Neurol; 1998 Mar; 245(3):149-52. PubMed ID: 9553844
[TBL] [Abstract][Full Text] [Related]
13. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
Beye A; Pindur G
Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.
Vandenbroucke JP; Koster T; Briët E; Reitsma PH; Bertina RM; Rosendaal FR
Lancet; 1994 Nov; 344(8935):1453-7. PubMed ID: 7968118
[TBL] [Abstract][Full Text] [Related]
17. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?
Turkstra F; Karemaker R; Kuijer PM; Prins MH; Büller HR
Thromb Haemost; 1999 Mar; 81(3):345-8. PubMed ID: 10102457
[TBL] [Abstract][Full Text] [Related]
18. Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives.
Bridey F; Wolff M; Laissy JP; Morin V; Lefebvre M; de Prost D
Thromb Haemost; 1995 Nov; 74(5):1382. PubMed ID: 8607129
[No Abstract] [Full Text] [Related]
19. Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden).
Pohl M; Zimmerhackl LB; Heinen F; Sutor AH; Schneppenheim R; Brandis M
J Pediatr; 1998 Jan; 132(1):159-61. PubMed ID: 9470020
[TBL] [Abstract][Full Text] [Related]
20. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
